The 20 Best Neuroblastoma Doctors Near Me in Bronx, NY

Daniel A. Weiser, MD, is a board-certified pediatric hematologist/oncologist with clinical expertise in neuroblastoma and tumors of the adrenal glands, kidneys, liver, and gonads. He serves as Director of the Abdominal Solid Tumor Program and Co-Director of the Childhood Cancer Predisposition (CCP) Clinic at the Children’s Hospital at Montefiore Einstein. Dr. Weiser leads a highly specialized, multidisciplinary team dedicated to providing comprehensive and individualized care for children with a broad spectrum of solid tumors. Dr. Weiser is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Adult Soft Tissue Sarcoma. Dr. Weiser is board certified in American Board Of Pediatrics.

Brian Kushner is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Kushner is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Desmoplastic Small Round Cell Tumor. Dr. Kushner is currently accepting new patients.

Nai-kong Cheung is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Cheung is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Desmoplastic Small Round Cell Tumor, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Cheung is currently accepting new patients.

Ellen Basu is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Basu is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Infantile Neutropenia. Dr. Basu is currently accepting new patients.

Suzanne Wolden is a Pediatric Radiologist practicing medicine in New York, New York. Dr. Wolden is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Rhabdomyosarcoma, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Orchiectomy. Dr. Wolden is currently accepting new patients.

Kim Kramer is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Kramer is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma. Dr. Kramer is currently accepting new patients.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

I am a pediatric oncologist who specializes in caring for children with solid tumors, especially neuroblastoma, Wilms' and other kidney tumors, and liver tumors such hepatoblastoma and hepatocellular carcinoma. I serve as chief of the Division of Hematology, Oncology and Stem Cell Transplantation at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital.I treat children of all ages, from infants to young adults. Some of the cancers I treat are rare (liver tumors account for one to two percent of childhood cancers), but they can be very complex and require a multidisciplinary approach so patients have the best outcomes. I enjoy working as part of a team of physicians, nurse practitioners, nurses, social workers, child life specialists, and other dedicated professionals who care deeply about our patients and provide care with compassion and comfort.I also conduct basic science research. The latest advances in tumor genetics and the design of innovative therapies make this a very exciting time for cancer research. My team and I have done extensive research on the genetics of hepatoblastoma. We have developed mouse models of this disease and are entering a new phase where we are offering a personalized/precision medicine approach to children with this disease. We are also identifying novel genes that specifically target neuroblastoma—information that may be used to create targeted therapies. Dr. Yamashiro is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Hepatoblastoma. Dr. Yamashiro is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Yamashiro is currently accepting new patients.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Lisa Gennarini, MD, has been an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplantation at Children's Hospital at Montefiore (CHAM) since 2014. Her clinical focus is on treatment of children with leukemia and lymphoma as well as various vascular anomalies. She is also the CHAM Principal Investigator for Children?s Oncology Group trials, and also leads the CHAM Vascular Malformations Program. Dr. Gennarini graduated from Siena College in 2004, earning her Bachelor of Science in Biology. In 2008, she received her Doctor of Medicine at State University of New York, Upstate Medical University in Syracuse. She began a residency in Pediatrics at Jefferson Medical College/A.I. duPont Hospital for Children, followed by a fellowship in Pediatric Hematology/Oncology at Children?s Hospital at Montefiore. Dr. Gennarini's work on pediatrics, topics ranging from sickle cell disease to implementing communications skills training courses in pediatric hematology/oncology, has been published in various journals and books, and presented nationally. Dr. Gennarini is board certified by the American Board of Pediatrics in Pediatric Hematology/Oncology and General Pediatrics. Dr. Gennarini is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, Bone Marrow Aspiration, and Adenoidectomy.

David Loeb, MD, PhD, is Chief, Pediatric Hematology, Oncology and Cellular Therapy at Children’s Hospital at Montefiore and Professor, Pediatrics and Professor, Developmental and Molecular Biology at Montefiore Einstein. His clinical work focuses on tumors of connective tissue, such as bone and muscle. He also has expertise in the care of children with other solid tumors. As a member of the bone marrow transplantation team, Dr. Loeb also cares for patients with acute leukemias and has expertise in the application of immunotherapy to childhood cancer. Dr. Loeb is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Bone Tumor.

Antonio Fojo is an Internal Medicine provider practicing medicine in New York, New York. Dr. Fojo is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma. Dr. Fojo is currently accepting new patients.

Gastro-Intestinal Cancer. Dr. Kaubisch is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.

Tarek Elrafei is an Oncologist practicing medicine in Bronx, New York. Dr. Elrafei is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Breast Cancer, Bone Marrow Aspiration, and Thrombectomy.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kahn is currently accepting new patients.

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment. Dr. Satwani is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Anemia, Sickle Cell Disease, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant. Dr. Satwani is board certified in Pediatric Hematology-Oncology. Dr. Satwani is currently accepting new patients.